{"id":"W3112543907","doi":"10.1093/ibd/izaa303","title":"Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry","year":2020,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Genentech; AbbVie; Leona M. and Harry B. Helmsley Charitable Trust; Pfizer; National Institute of Diabetes and Digestive and Kidney Diseases; Bristol-Myers Squibb Canada; Boehringer Ingelheim; Eli Lilly and Company","keywords":"Tofacitinib; Medicine; Coronavirus disease 2019 (COVID-19); Ulcerative colitis; Inflammatory bowel disease; Inflammatory Bowel Diseases; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Virology; Immunology; Internal medicine; Rheumatoid arthritis; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001166503,0.0003105145,0.0002478307,0.00004753797,0.00009702631,0.00004346569,0.0003603827,0.0001164009,0.00003687598],"category_scores_gemma":[0.0005509273,0.0002176375,0.0001061372,0.00007426479,0.0002943807,0.00001475049,0.00007944836,0.000131482,0.000006355278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001876339,"about_ca_system_score_gemma":0.0002708212,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004242218,"about_ca_topic_score_gemma":0.00001056305,"domain_scores_codex":[0.9983786,0.0001957057,0.0003812148,0.0004369173,0.0003417582,0.0002657736],"domain_scores_gemma":[0.9986948,0.00006962755,0.0002507848,0.0005361722,0.00008923653,0.0003593435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002322205,0.0002158011,0.9948295,0.0001802788,0.00007394971,0.0002004228,0.0004998944,0.00003718563,0.0002398236,0.0002363348,0.0008796368,0.0002849312],"study_design_scores_gemma":[0.002502489,0.0002835037,0.991107,0.00002210602,0.00003353371,0.000001350397,0.0002115303,0.00001230024,0.0001592665,0.00003908016,0.005347941,0.0002798529],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975914,0.0001185636,0.00001799435,0.0005184574,0.00004503175,0.0006366966,0.0009107098,0.00002701548,0.0001340788],"genre_scores_gemma":[0.9938228,0.00009360322,0.00001563786,0.005492196,0.0001021968,0.00006262651,0.0003602618,0.00003573686,0.00001498086],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004973739,"threshold_uncertainty_score":0.8875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01107671697525935,"score_gpt":0.2430421881232821,"score_spread":0.2319654711480227,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}